IP Verse

Szynka patent opposition analysis

The comprehensive analysis of Szynka opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Szynka

Stay updated with the latest patent oppositions filed by Szynka

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3819007
Dosing Regimen For Anti-Bcma AgentsAMGENApr 9, 2025ABBVIE
EP3669338
Passive Care Control Method And Associated SystemsMICASJan 24, 2025GEBERIT
EP4058148
Dosing Regimen For Anti-Bcma AgentsAMGEN RESEARCH MUNICHDec 13, 2024ABBVIE
EP4209499
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENSep 23, 2024HEMSATH
EP3880089
Shock Wave Apparatus And Method For Treating A Human Or Animal BodyFERTON HOLDINGSep 13, 2024STORZ MEDICAL
EP3823992
Anti-Lypd3 Car T-Cell Therapy For The Treatment Of CancerDUKE UNIVERSITYSep 12, 2024HEMSATH
EP3814496
Sample Preparation Method And SystemGEN PROBE INCORPORATEDAug 22, 2024QIAGEN
EP3334747
Charged Depth Filtration Of Antigen-Binding ProteinsAMGENJun 27, 2024HEMSATH
EP3631454
Treatment Of Lag-3 Positive TumorsBRISTOL MYERS SQUIBBJun 3, 2024ROTH
EP3701220
Method And Apparatus For Measuring The Straightness Error Of Slender Bodies, With Compensation Of Gravity DeformationQ TECHMay 29, 2024MSG MASCHINENBAU

Top clients of Szynka

Top companies who are the clients of Szynka

CompanyTotal
KONIG SZYNKA TILMANN VON RENESSE41
GEBERIT19
ABBVIE8
HAUFF TECHNIK6
QIAGEN6
ROTH4
HEXAL4
BAYER3
HEMSATH3
SURFACTOR GERMANY3